Brief: Rhythm Pharmaceuticals Secures $150 Million In Convertible Preferred Stock Financing
01/04/2024 17:50
April 1 (Reuters) - Rhythm Pharmaceuticals Inc RYTM.O :
* RHYTHM PHARMACEUTICALS SECURES $150 MILLION IN CONVERTIBLE
PREFERRED STOCK FINANCING
* RHYTHM PHARMACEUTICALS:INTENDS TO USE PROCEEDS FROM
OFFERING TO
FUND CLINICAL DEVELOPMENT PROGRAMS & COMMERCIALIZATION
ACTIVITIES, FOR WORKING CAPITAL
* RHYTHM PHARMACEUTICALS INC: PREFERRED STOCK FINANCING
EXPECTED
TO EXTEND CO'S CASH RUNWAY WELL INTO 2026
Source text for Eikon: ID:nGNXML0Qy
Further company coverage: RYTM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Pharmaceuticals
See all newsBrief: Rhythm Pharmaceuticals Announces Appointment Of Manher (Aj) Joshi As Chief Medical Officer
Rhythm's drug shows promise for brain tumor-related weight condition in small study (updated)
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Rhythm Pharma's obesity drug shows promise for brain tumor-related weight condition
Rhythm Pharmaceuticals Q2 net loss narrows on US launch demand